DIA
FBIO icon

Denver Investment Advisors’s Fortress Biotech FBIO Stock Holding History

Denver Investment Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$93K Sell
1,361
-313
-19% -$19.8K ﹤0.01% 407
2017
Q4 		$100K Hold
1,674
– – 0.01% 415
2017
Q3 		$111K Hold
1,674
– – 0.01% 431
2017
Q2 		$119K Hold
1,674
– – 0.01% 434
2017
Q1 		$93K Hold
1,674
– – ﹤0.01% 452
2016
Q4 		$68K Hold
1,674
– – ﹤0.01% 461
2016
Q3 		$75K Sell
1,674
-120
-7% -$5.1K ﹤0.01% 429
2016
Q2 		$72K Sell
1,794
-376
-17% -$17.5K ﹤0.01% 440
2016
Q1 		$101K Sell
2,170
-689
-24% -$29.1K ﹤0.01% 438
2015
Q4 		$120K Sell
2,859
-324
-10% -$13.6K 0.01% 475
2015
Q3 		$124K Sell
3,183
-110
-3% -$5.14K 0.01% 493
2015
Q2 		$166K Sell
3,293
-899
-21% -$46.1K 0.01% 515
2015
Q1 		$242K Sell
4,192
-89
-2% -$3.71K 0.01% 531
2014
Q4 		$157K Buy
4,281
+18
+0.4% +$530 0.01% 586
2014
Q3 		$134K Buy
4,263
+241
+6% +$6.4K ﹤0.01% 573
2014
Q2 		$104K Buy
+4,022
New +$106K ﹤0.01% 603

Other funds holding FBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Denver Investment Advisors's FBIO Position: Q1 2018 in Review

Denver Investment Advisors reduced its Fortress Biotech (FBIO) stake by 19% in Q1 2018, selling an estimated $19.8K and leaving 1,361 shares worth $93K. The position accounts for ﹤0.01% of the portfolio, ranked #407.

Denver Investment Advisors first reported a position in FBIO in Q2 2014 and has held it in 16 quarters since. The position peaked at $242K in Q1 2015. 66 funds tracked by Wall St. Rank hold FBIO as of Q1 2018.

  • Denver Investment Advisors held 1,361 shares of Fortress Biotech worth $93K as of Q1 2018.
  • Denver Investment Advisors sold 313 Fortress Biotech shares in Q1 2018, an estimated $19.8K.
  • Fortress Biotech made up ﹤0.01% of Denver Investment Advisors's portfolio in Q1 2018, its #407 holding.
  • Denver Investment Advisors first reported a position in Fortress Biotech in Q2 2014 and has held it in 16 quarters since.
  • Denver Investment Advisors's Fortress Biotech position peaked at $242K in Q1 2015.
  • 66 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2018.

Based on Denver Investment Advisors's 13F filing for Q1 2018, filed 10 May 2018.